Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
12.82
+0.41 (3.30%)
At close: Nov 22, 2024, 4:00 PM
12.70
-0.12 (-0.94%)
After-hours: Nov 22, 2024, 5:32 PM EST
Sotera Health Company Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$16.50
Upside
+28.71%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +56.01% | Nov 6, 2024 |
| Barclays | Barclays | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +32.61% | Aug 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +32.61% | Aug 6, 2024 |
| Piper Sandler | Piper Sandler | Hold Initiates $13 | Hold | Initiates | $13 | +1.40% | May 21, 2024 |
| Barclays | Barclays | Buy Maintains $19 → $14 | Buy | Maintains | $19 → $14 | +9.20% | Apr 10, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $18 → $16 | Hold → Strong Buy | Upgrades | $18 → $16 | +24.80% | Apr 3, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $15 → $16 | Hold → Strong Buy | Upgrades | $15 → $16 | +20.90% | Mar 25, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +56.01% | Mar 11, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +56.01% | Mar 4, 2024 |
| Barclays | Barclays | Buy Maintains $17 → $19 | Buy | Maintains | $17 → $19 | +48.21% | Feb 28, 2024 |
| Keybanc | Keybanc | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 6, 2024 |
| Barclays | Barclays | Buy Maintains $15 → $17 | Buy | Maintains | $15 → $17 | +32.61% | Jan 25, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $22 → $20 | Buy | Maintains | $22 → $20 | +56.01% | Nov 2, 2023 |
| Barclays | Barclays | Buy Maintains $20 → $15 | Buy | Maintains | $20 → $15 | +17.00% | Nov 2, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $18 → $22 | Buy | Maintains | $18 → $22 | +71.61% | Aug 4, 2023 |
| Keybanc | Keybanc | Buy Maintains $24 → $23 | Buy | Maintains | $24 → $23 | +79.41% | Aug 4, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.